118 related articles for article (PubMed ID: 22475901)
1. FDG PET/CT of a late-term pregnant woman with breast cancer.
Hsieh TC; Wu YC; Sun SS; Chu LY; Yen KY; Kao CH
Clin Nucl Med; 2012 May; 37(5):489-91. PubMed ID: 22475901
[TBL] [Abstract][Full Text] [Related]
2. Absorbed 18F-FDG dose to the fetus during early pregnancy.
Zanotti-Fregonara P; Jan S; Taieb D; Cammilleri S; Trébossen R; Hindié E; Mundler O
J Nucl Med; 2010 May; 51(5):803-5. PubMed ID: 20395321
[TBL] [Abstract][Full Text] [Related]
3. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR.
Zanotti-Fregonara P; Laforest R; Wallis JW
J Nucl Med; 2015 Aug; 56(8):1218-22. PubMed ID: 26089550
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG Whole-body PET/MRI of a 30-Week Pregnant Woman With Breast Cancer Revealed Interesting Fetal Findings.
Blanc-Durand P; Milliner M; Huchet V; Luciani A; Itti E
Clin Nucl Med; 2019 Oct; 44(10):818-820. PubMed ID: 31205152
[TBL] [Abstract][Full Text] [Related]
5. Estimated Fetal Radiation Dose From 18 F-FDG PET/CT During the Second and Third Trimesters of Pregnancy.
Al Mansour L; Tylski P; Chene G; Plaisant F; Janier M; Bolze PA; You B; Defez D; Tordo J; Flaus A
Clin Nucl Med; 2024 Jul; 49(7):605-609. PubMed ID: 38778468
[TBL] [Abstract][Full Text] [Related]
6.
Zanotti-Fregonara P; Ishiguro T; Yoshihara K; Ishii S; Enomoto T
J Nucl Med; 2022 Oct; 63(10):1592-1597. PubMed ID: 35115366
[TBL] [Abstract][Full Text] [Related]
7. Fetal Dose from PET and CT in Pregnant Patients.
Burton CS; Frey K; Fahey F; Kaminski MS; Brown RKJ; Pohlen JM; Shulkin BL
J Nucl Med; 2023 Feb; 64(2):312-319. PubMed ID: 36215573
[TBL] [Abstract][Full Text] [Related]
8. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
[TBL] [Abstract][Full Text] [Related]
9. Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.
Koolen BB; Vidal-Sicart S; Benlloch Baviera JM; Valdés Olmos RA
Nucl Med Commun; 2014 May; 35(5):446-52. PubMed ID: 24686195
[TBL] [Abstract][Full Text] [Related]
10. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
Xie T; Zaidi H
J Nucl Med; 2014 Sep; 55(9):1459-66. PubMed ID: 25024424
[TBL] [Abstract][Full Text] [Related]
11. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid.
Keleher A; Wendt R; Delpassand E; Stachowiak AM; Kuerer HM
Breast J; 2004; 10(6):492-5. PubMed ID: 15569204
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
13. Performance of FDG PET/CT in the clinical management of breast cancer.
Groheux D; Espié M; Giacchetti S; Hindié E
Radiology; 2013 Feb; 266(2):388-405. PubMed ID: 23220901
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
[TBL] [Abstract][Full Text] [Related]
15. A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.
Treglia G; Muoio B; Caldarella C; Parapatt GK
Clin Nucl Med; 2014 Mar; 39(3):e233-5. PubMed ID: 23603592
[TBL] [Abstract][Full Text] [Related]
16. New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.
Zanotti-Fregonara P; Chastan M; Edet-Sanson A; Ekmekcioglu O; Erdogan EB; Hapdey S; Hindie E; Stabin MG
J Nucl Med; 2016 Nov; 57(11):1760-1763. PubMed ID: 27261522
[TBL] [Abstract][Full Text] [Related]
17. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.
Zanotti-Fregonara P; Koroscil TM; Mantil J; Satter M
Health Phys; 2012 Feb; 102(2):217-9. PubMed ID: 22217594
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperstimulation and breast cancer on PET imaging with sonographic correlation.
Cunningham JR; O'Malley JP; Bhambhvani P
Clin Nucl Med; 2015 May; 40(5):430-2. PubMed ID: 25742224
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
[TBL] [Abstract][Full Text] [Related]
20. Unilateral breast metastasis from alveolar rhabdomyosarcoma in adult detected by ¹⁸F-FDG PET/CT.
Cárdenas-Perilla R; Simó-Perdigó M; Barios-Profitós M; Castell-Conesa J
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):148-9. PubMed ID: 25053243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
